Estrazinol
Clinical data | |
---|---|
Other names | 3-Methoxy-8-aza-19-norpregna-1,3,5(10)-trien-20-yn-17-ol; W-4454A |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C20H25NO2 |
Molar mass | 311.425 g·mol−1 |
3D model (JSmol) | |
| |
|
Estrazinol (INN; also known as estrazinol hydrobromide (USAN), 3-methoxy-8-aza-19-norpregna-1,3,5(10)-trien-20-yn-17-ol, or development code W-4454A) is a synthetic, steroidal estrogen that was synthesized in 1968 and further characterized in 1973 but was never marketed.[1] It is described as a water-soluble estrogen.[2]
References
- ^ J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. p. 503. ISBN 978-1-4757-2085-3.
- ^ Rassaert CL, DiPasquale G, Giannina T, Manning JP, Meli A (1973). "Estrogenic profile on a water-soluble estrogen, estrazinol hydrobromide". Steroids Lipids Res. 4 (5): 333–40. PMID 4368700.